To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
I have been investing for past 10 years and my focus is mainly concentrated in healthcare sector. I trade on momentnum on news such as major upcoming topline clinical trial results, FDA approval etc.
See Seeking Alpha's policy on anonymous authors.
Stocks - long
Currently, there is no company profile for gohsi.
Currently, there are no blog details for gohsi.
Currently, there are no book details for gohsi.
. No catalyst at the moment but risk/reward ratio looks good with current price under $1.70
Aug 11, 2014
Plumiaz get a CRL and Actav...
Next Chapter In The Acorda Story Will Be A Page...
Patient enrollment has been...
Regado Biosciences: The Revolixys Revolution Ha...
If you look at previous yea...
Lumenis IPO Could Shine Strong
Amy, nice article. I have r...
Genomic Health's New Prostate Test May Extend T...
What would be target of the...
CytRx Awaiting Soft Tissue Sarcoma Data In Dece...
Time To Get On Board Before Binary Event
An Undervalued Company Punished For Wrong Reasons
Xignite quote data
© 2014 Seeking Alpha